Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 1)
Topiramate Capsule, Extended Release
Product Images NDC 10370-368
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10370-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 2)
This text represents a numeric value of 0.0002.*
Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 3)
Topiramate 200 mg (Topiramate Extended Release Capsules 200 mg 4)
This is a medication containing topiramate, with extended-release capsules that should be swallowed whole and not opened, crushed or sprinkled on food. The pharmacist should dispense it with the medication guide, and it should be stored at room temperature, protected from moisture and light, and kept out of reach of children. The dosage and other information can be found in the package outsert. The medication was manufactured by Par Formulations Private Limited in India and distributed by Par Pharmaceutical in the US.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
